Intellipharmaceutics International Inc. (IPCI)

[fabius]

You can be right,
but remember that IPCI is not a single drug company, it is a really small co. (and therfore made some mistakes along the road) but has a lot of potential.

It's true that generics in the pipeline are small deals compared to the NDAs, but if FDA decides that 5 years of waiting its enough to get an approval, then we should start see some nice additional and increasing revenue (as approvals start to come) to sustain the development of the much more lucrative drugs.

This point is crucial: just FDA action on generics ! and the stock will greatly benefit in the coming months...

IPCI could become profitable just with the generics royalties, (but it's in the FDA hands)...Rexista and Poddras will then push to price much much higher then 6-8 $.

Let's wait and see what kind of partnership will come out for Rexista (I would strongly vote for a Purdue mega-deal on all the opioids Platform)